EXINI Diagnostics AB - Product Pipeline Analysis, 2017 Update
"EXINI
Diagnostics AB - Product Pipeline Analysis, 2017 Update"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Summary
EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare IT company that offers development of software solutions for the medical diagnostic market. The companys software solutions include EXINIbone, EXINIheart, EXINIbrain and EXINIdat. Its EXINIbone is used in analysis of bone scintigraphy; and EXINIheart provides analysis of myocardial perfusion scintigraphy. EXINIs EXINIbrain is used for diagnosing dementia by processing cerebral blood flow scans; and EXINIdat is used for diagnosing Parkinsonian syndromes using quantification of striatal uptake. The company provides image analysis, display of images, pre-selection of hotspot, bone scan index and qualification, Bone scan index report, handling of large databases, and artificial neural networks for increasing accuracy and improving clinical time-flow. It offers products in the fields of oncology, cardiology, and neurology. The company serves in quality, patenting, marketing and publicizing. EXINI is headquartered in Lund, Sweden.
EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare IT company that offers development of software solutions for the medical diagnostic market. The companys software solutions include EXINIbone, EXINIheart, EXINIbrain and EXINIdat. Its EXINIbone is used in analysis of bone scintigraphy; and EXINIheart provides analysis of myocardial perfusion scintigraphy. EXINIs EXINIbrain is used for diagnosing dementia by processing cerebral blood flow scans; and EXINIdat is used for diagnosing Parkinsonian syndromes using quantification of striatal uptake. The company provides image analysis, display of images, pre-selection of hotspot, bone scan index and qualification, Bone scan index report, handling of large databases, and artificial neural networks for increasing accuracy and improving clinical time-flow. It offers products in the fields of oncology, cardiology, and neurology. The company serves in quality, patenting, marketing and publicizing. EXINI is headquartered in Lund, Sweden.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=1256560
This
report is a source for data, analysis, and actionable intelligence on
the companys portfolio of pipeline products. The report provides key
information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EXINI Diagnostics AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EXINI Diagnostics AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
EXINI Diagnostics AB Company Overview 4
EXINI Diagnostics AB Company Snapshot 4
EXINI Diagnostics AB Pipeline Products and Ongoing Clinical Trials Overview 4
EXINI Diagnostics AB Pipeline Analysis Overview 7
EXINI Diagnostics AB - Key Facts 7
EXINI Diagnostics AB - Major Products and Services 8
EXINI Diagnostics AB Pipeline Products by Development Stage 9
EXINI Diagnostics AB Pipeline Products Overview 11
cardioREPO 11
cardioREPO Product Overview 11
EXINI Kidney 12
EXINI Kidney Product Overview 12
EXINI PET 13
EXINI PET Product Overview 13
EXINI Diagnostics AB - Key Competitors 14
EXINI Diagnostics AB - Key Employees 15
EXINI Diagnostics AB - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
EXINI Diagnostics AB, Recent Developments 17
Apr 18, 2013: Exini Diagnostics Launches Major Upgrade Of Exini Bone In Japan 17
Apr 03, 2013: Exini Diagnostics Get Funding From Vinnova To Develop Software For Analysis Of Cancers From 2D To 3D 17
Feb 17, 2012: EXINI Reports Revenue Of SEK11.6m In 2011 17
Feb 02, 2012: EXINI Diagnostics Announces Publication Of Clinical Results Of EXINI bone In European Urology 18
Nov 04, 2011: EXINI Diagnostics Highlights BONENAVI At Annual Meetings Of JSNM2011 And JSNMT31 18
Oct 28, 2011: EXINI Reports Revenue Of SEK2.4m In Q3 2011 19
Oct 18, 2011: Exini Software Brings Added Value To New Technology 19
Oct 07, 2011: EXINI Diagnostics To Attend Annual Congress Of EANM, Birmingham 19
Oct 07, 2011: EXINI Diagnostics Announces Updated Version With Improved Functions Of Bonenavi 1.0.1 20
Oct 04, 2011: EXINI Diagnostics Receives Approval For Listing At NASDAQ OMX First North 20
Appendix 21
Methodology 21
Table of Contents 2
List of Tables 3
List of Figures 3
EXINI Diagnostics AB Company Overview 4
EXINI Diagnostics AB Company Snapshot 4
EXINI Diagnostics AB Pipeline Products and Ongoing Clinical Trials Overview 4
EXINI Diagnostics AB Pipeline Analysis Overview 7
EXINI Diagnostics AB - Key Facts 7
EXINI Diagnostics AB - Major Products and Services 8
EXINI Diagnostics AB Pipeline Products by Development Stage 9
EXINI Diagnostics AB Pipeline Products Overview 11
cardioREPO 11
cardioREPO Product Overview 11
EXINI Kidney 12
EXINI Kidney Product Overview 12
EXINI PET 13
EXINI PET Product Overview 13
EXINI Diagnostics AB - Key Competitors 14
EXINI Diagnostics AB - Key Employees 15
EXINI Diagnostics AB - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
EXINI Diagnostics AB, Recent Developments 17
Apr 18, 2013: Exini Diagnostics Launches Major Upgrade Of Exini Bone In Japan 17
Apr 03, 2013: Exini Diagnostics Get Funding From Vinnova To Develop Software For Analysis Of Cancers From 2D To 3D 17
Feb 17, 2012: EXINI Reports Revenue Of SEK11.6m In 2011 17
Feb 02, 2012: EXINI Diagnostics Announces Publication Of Clinical Results Of EXINI bone In European Urology 18
Nov 04, 2011: EXINI Diagnostics Highlights BONENAVI At Annual Meetings Of JSNM2011 And JSNMT31 18
Oct 28, 2011: EXINI Reports Revenue Of SEK2.4m In Q3 2011 19
Oct 18, 2011: Exini Software Brings Added Value To New Technology 19
Oct 07, 2011: EXINI Diagnostics To Attend Annual Congress Of EANM, Birmingham 19
Oct 07, 2011: EXINI Diagnostics Announces Updated Version With Improved Functions Of Bonenavi 1.0.1 20
Oct 04, 2011: EXINI Diagnostics Receives Approval For Listing At NASDAQ OMX First North 20
Appendix 21
Methodology 21
Full
Report @
http://www.researchmoz.us/exini-diagnostics-ab-product-pipeline-analysis-2017-update-report.html
Comments
Post a Comment